The document discusses the concept of outsourcing, particularly in the pharmaceutical industry, and emphasizes its importance for conducting bioavailability and bioequivalence studies. It outlines reasons for outsourcing, typical services provided by contract research organizations (CROs), advantages, and key success elements for these collaborations. Additionally, it highlights critical considerations regarding timing, costs, and potential problems associated with outsourcing.